COVID-19 pneumonia and ominous methemoglobinemia: Causation or confounding
<p dir="ltr">Severe COVID-19 pneumonia and methemoglobinemia share many presenting clinical features, and it is unclear whether this may have been predominantly due to a dramatic increase in the use of oxidizing medications, which were used to treat COVID-19 during the pandemic, or C...
محفوظ في:
| المؤلف الرئيسي: | Wael Goravey (14777254) (author) |
|---|---|
| مؤلفون آخرون: | Gawahir A. Ali (14777260) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Methylene blue-induced Hemolysis in a patient with lidocaine-induced Methemoglobinemia: a case report
حسب: Murad Mehmood (23125915)
منشور في: (2025) -
Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial
حسب: Alaa Rahhal (14150403)
منشور في: (2022) -
Can AI Help in Screening Viral and COVID-19 Pneumonia?
حسب: Muhammad E. H. Chowdhury (14150526)
منشور في: (2020) -
Congenital Methemoglobinemia: First Confirmed Case in the Arab Population with a Novel Variant in the <i>CYB5R</i> Gene in the State of Qatar: A Case Report
حسب: Abdulrahman Al-Abdulmalek (16329091)
منشور في: (2023) -
Ominous combination: COVID‐19 disease and <i>Candida auris</i> fungemia—Case report and review of the literature
حسب: Wael Goravey (14777254)
منشور في: (2023)